Efficacy and safety of combined aspirin and warfarin therapy after heart valve replacement: a systematic review and meta-analysis of randomized clinical trials
Open Access
- 13 September 2022
- journal article
- review article
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 27 (3S), 4993
- https://doi.org/10.15829/1560-4071-2022-4933
Abstract
Aim. To conduct a systematic review and meta-analysis of the efficacy and safety of combined oral anticoagulant therapy with vitamin K antagonists (VKA) and antiplatelet therapy with aspirin compared with VKA monotherapy in patients after mechanical valve replacement.Material and methods. We searched the PubMed, Google Scholar databases for studies comparing the risk of thromboembolic events, major bleeding, and mortality in VKA monotherapy versus combined aspirin and VKA therapy in patients with mechanical valve replacement.Results. Eight randomized clinical trials were selected for this systematic review and meta-analysis. In total, 4082 patients were included in the analysis (mean age, 50,8 years, men — 2484 (60,9%)). A meta-analysis showed that the addition of aspirin to VKA, compared with VKA monotherapy, significantly reduced the incidence of thromboembolic events (odds ratio (OR) 0,47; 95% confidence interval (CI): 0,33-0,67; pConclusion. The addition of aspirin to VKA, compared with VKA monotherapy, reduces the risk of systemic embolism and death in patients after mechanical valve replacement. At the same time, the risk of major bleeding did not differ between the groups.Keywords
This publication has 21 references indexed in Scilit:
- Guidelines on the management of valvular heart disease (version 2012)European Heart Journal, 2012
- Anticoagulation therapy with combined low dose aspirin and warfarin following mechanical heart valve replacementThrombosis Research, 2011
- Low-Intensity Oral Anticoagulant Plus Low-Dose Aspirin During the First Six Months Versus Standard-Intensity Oral Anticoagulant Therapy After Mechanical Heart Valve Replacement: A Pilot Study of Low-Intensity Warfarin and Aspirin in Cardiac Prostheses (LIWACAP)Clinical and Applied Thrombosis/hemostasis, 2007
- Early and long-term (one-year) effects of the association of aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the st. jude medical prosthesis: A clinical and transesophageal echocardiographic studyJournal of Invasive Cardiology, 2000
- Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: A randomized trial in patients with mechanical prosthetic heart valvesThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Optimal Oral Anticoagulant Therapy in Patients with Mechanical Heart ValvesThe New England Journal of Medicine, 1995
- Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses.Journal of the American College of Cardiology, 1994
- A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve ReplacementThe New England Journal of Medicine, 1993
- Antithrombotic therapy in patients with valvular heart disease and prosthetic heart valvesJournal of Invasive Cardiology, 1986
- Prevention of arterial thromboembolism with acetylsalicylic acid: A controlled clinical study in patients with aortic ball valvesAmerican Heart Journal, 1977